Free Trial
→ I've got news for you… (From DTI) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 9 of 15

Slide 9
Back to 8
Continue to 10
 
Back to 8
Continue to 10
 

United Therapeutics (NASDAQ:UTHR)

Consensus Rating
Moderate Buy
Rating Score
2.7
Ratings Breakdown
12 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$370.86 (0.8% Downside)

About United Therapeutics

United Therapeutics logoUnited Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/1/2024The Goldman Sachs GroupBoost Price TargetNeutral ➝ Neutral$243.00 ➝ $302.00
10/31/2024LADENBURG THALM/SH SHBoost Price TargetBuy ➝ Buy$319.00 ➝ $344.00
10/31/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$575.00 ➝ $600.00
10/31/2024HC WainwrightBoost Price TargetBuy ➝ Buy$400.00 ➝ $425.00
10/31/2024ArgusBoost Price TargetBuy ➝ Buy$360.00 ➝ $400.00
10/21/2024TD CowenBoost Price TargetBuy ➝ Buy$350.00 ➝ $400.00
9/23/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$315.00 ➝ $432.00
8/28/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$400.00 ➝ $575.00
8/20/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$350.00 ➝ $380.00
8/1/2024LADENBURG THALM/SH SHDowngradeStrong-Buy ➝ Hold
Slide 9
Back to 8
Continue to 10
 

I've got news for you… (Ad)

Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week

watch this FREE briefing with me and expert trader Graham Lindman

More From MarketBeat
Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
7 Artificial Intelligence Stocks That Are Still Long-Term Winners
It's hard to believe that two years ago, many of us had never heard of ChatGPT. But for the last 18 months, in...
MarketBeat
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
8 Retail Stocks to Own For the Long Haul
After the 2020 e-commerce boom, everyone thought we had taken a 10-year leap in online shopping. Amazon was op...
MarketBeat
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
7 Chip Stocks Leading the AI Revolution
Artificial intelligence (AI) has been around for longer than many investors may think. However, the launch of ...
MarketBeat